The Management of Myelomeningocele Study: full cohort 30-month pediatric outcomes

Ouyang, 2007, Health care expenditures of children and adults with spina bifida in a privately insured US population, Birth Defects Res A Clin Mol Teratol, 79, 552, 10.1002/bdra.20360

Centers for Disease Control, 1989, Economic burden of spina bifida–United States, 1980-1990, MMWR Morb Mortal Wkly Rep, 38, 264

Farmer, 2003, In-utero repair of myelomeningocele: experimental pathophysiology, initial clinical experience, and outcomes, Arch Surg, 138, 872, 10.1001/archsurg.138.8.872

Johnson, 2003, Fetal myelomeningocele repair: short-term clinical outcomes, Am J Obstet Gynecol, 189, 482, 10.1067/S0002-9378(03)00295-3

Johnson, 2006, Maternal-fetal surgery for myelomeningocele: neurodevelopmental outcomes at 2 years of age, Am J Obstet Gynecol, 194, 1145, 10.1016/j.ajog.2006.01.072

Danzer, 2009, Lower extremity neuromotor function and short-term ambulatory potential following in utero myelomeningocele surgery, Fetal Diagn Ther, 25, 47, 10.1159/000197359

Danzer, 2008, Reversal of hindbrain herniation after maternal-fetal surgery for myelomeningocele subsequently impacts on brain stem function, Neuropediatrics, 39, 359, 10.1055/s-0029-1202835

Adzick, 2011, A randomized trial of prenatal versus postnatal repair of myelomeningocele, N Engl J Med, 364, 993, 10.1056/NEJMoa1014379

Johnson, 2016, The Management of Myelomeningocele Study: obstetrical outcomes and risk factors for obstetrical complications following prenatal surgery, Am J Obstet Gynecol, 215, 778.e1, 10.1016/j.ajog.2016.07.052

Tulipan, 2015, Prenatal surgery for myelomeningocele and the need for cerebrospinal fluid shunt placement, J Neurosurg Pediatr, 16, 613, 10.3171/2015.7.PEDS15336

Brock, 2015, Bladder function after fetal surgery for myelomeningocele, Pediatrics, 136, e906, 10.1542/peds.2015-2114

Kabagambe, 2017, Fetal surgery for myelomeningocele: a systematic review and meta-analysis of outcomes in fetoscopic vs open repair, Fetal Diagn Ther

Wang, 2015, Placental mesenchymal stromal cells rescue ambulation in ovine myelomeningocele, Stem Cells Transl Med, 4, 659, 10.5966/sctm.2014-0296

Brown, 2016, Age does matter: a pilot comparison of placenta-derived stromal cells for in utero repair of myelomeningocele using a lamb model, Fetal Diagn Ther, 39, 179, 10.1159/000433427

Watanabe, 2016, Complete tissue coverage achieved by scaffold-based tissue engineering in the fetal sheep model of myelomeningocele, Biomaterials, 76, 133, 10.1016/j.biomaterials.2015.10.051

Watanabe, 2011, A tissue engineering approach for prenatal closure of myelomeningocele: comparison of gelatin sponge and microsphere scaffolds and bioactive protein coatings, Tissue Eng Part A, 17, 1099, 10.1089/ten.tea.2010.0390

Dionigi, 2015, Trans-amniotic stem cell therapy (TRASCET) minimizes Chiari-II malformation in experimental spina bifida, J Pediatr Surg, 50, 1037, 10.1016/j.jpedsurg.2015.03.034

Feng, 2016, A comparison between placental and amniotic mesenchymal stem cells for transamniotic stem cell therapy (TRASCET) in experimental spina bifida, J Pediatr Surg, 51, 1010, 10.1016/j.jpedsurg.2016.02.071

Tarui, 2017, Amniotic fluid transcriptomics reflects novel disease mechanisms in fetuses with myelomeningocele, Am J Obstet Gynecol, 217, 587.e1, 10.1016/j.ajog.2017.07.022